A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients
Oncology Research · 2024
DOI: 10.32604/or.2023.043922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Yan Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: Bortezomib, Peripheral Nervous System Diseases, Polymorphism, Single Nucleotide, Multiple Myeloma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Zitieren
APA
Zhang, Y., Zhang, H., Wang, J., Wei, X., Qu, Y. I., Xu, F., & Zhang, L. (2024). A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients. Oncology Research. https://doi.org/10.32604/or.2023.043922
Vancouver
Zhang Y, Zhang H, Wang J, Wei X, Qu YI, Xu F, et al. A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients. Oncology Research. 2024. doi:10.32604/or.2023.043922
BibTeX
@article{Zhang2024,
author = {Zhang, Yan and Zhang, Heyang and Wang, Jing and Wei, Xin and Qu, Y I and Xu, Feng and Zhang, Lijun},
title = {A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients},
journal = {Oncology Research},
year = {2024},
doi = {10.32604/or.2023.043922}
}
EUVIMED